MTL Cannabis Corp. (MTLC), a leading cannabis company, announced strong financial results for the first quarter of 2025, ending June 30th. The company reported a substantial increase in revenue, reaching $25,842,264, a 53% improvement compared to the same period in the previous year. This growth was driven by a significant increase in net revenue, reaching $20,721,232, a 62% increase year-over-year.
MTL Cannabis also achieved a notable improvement in profitability, with a gross margin before fair value adjustments of 54%, a 16% increase compared to the previous year. The company’s focus on producing high-quality cannabis products, including dried flower, pre-rolls, and hash, marketed under the “MTL Cannabis”, “Low Key by MTL”, and “R’belle” brands, has contributed to its success.
The company’s commitment to the medical cannabis market is also driving its growth. Abba Medix Corp., a subsidiary of MTL Cannabis, operates a leading medical cannabis marketplace, and Canada House Clinics Inc. provides specialized cannabinoid therapy services to patients across Canada.
MTL Cannabis’ strong financial performance is reflected in its cash flow statement. The company generated net cash inflows from operating activities of $5,602,954, a significant improvement compared to the same period last year.
“We are incredibly proud of our team and the progress we have made as a company,” said Michael Perron, CEO of MTL. “We look forward to continuing to deliver best in class products and services to our incredible customers and patients.”
MTL Cannabis is well-positioned for continued growth in the evolving cannabis market. Its focus on high-quality products, strategic expansion into the medical cannabis market, and commitment to providing exceptional customer service will continue to drive its success.
